Newron Pharmaceuticals SpA (XTER:NP5) Interest Expense : €-4.32 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Newron Pharmaceuticals SpA's interest expense for the six months ended in Jun. 2024 was € -2.18 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.32 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Newron Pharmaceuticals SpA's Operating Income for the six months ended in Jun. 2024 was € -7.68 Mil. Newron Pharmaceuticals SpA's Interest Expense for the six months ended in Jun. 2024 was € -2.18 Mil. Newron Pharmaceuticals SpA did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Newron Pharmaceuticals SpA Interest Expense Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Interest Expense Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.57

-2.24

-2.92

-3.95

-4.17

Newron Pharmaceuticals SpA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-1.91	-2.04	-2.03	-2.14	-2.18

Newron Pharmaceuticals SpA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.32 Mil.

Newron Pharmaceuticals SpA (XTER:NP5) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Newron Pharmaceuticals SpA's Interest Expense for the six months ended in Jun. 2024 was €-2.18 Mil. Its Operating Income for the six months ended in Jun. 2024 was €-7.68 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was €48.67 Mil.

Newron Pharmaceuticals SpA's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Newron Pharmaceuticals SpA did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Newron Pharmaceuticals SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NWPHF:USA 0QOI:UK NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Stefan Weber	Board of Directors
Dr. Ulrich Köstlin	Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines